Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their BodyFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, renal cell carcinoma, skin disorder, skin neoplasm, urinary system disorderRecruitingPhase 1 / Phase 22026-04-28NCT06413680

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Regeneron Pharmaceuticals238

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
MD Anderson Cancer CenterHoustonUnited States589
NEXT OncologySan AntonioUnited States70
Northwell HealthLake SuccessUnited States25
Start Midwest Cancer ResearchGrand RapidsUnited States1
The START Center for Cancer CareSan AntonioUnited States2
University of California San Francisco (UCSF)San FranciscoUnited States13
University of ChicagoChicagoUnited States312
University of North Carolina At Chapel HillChapel HillUnited States50
University of Pittsburgh Medical Center - Hillman Cancer CenterPittsburghUnited States6
Usc Norris Comprehensive Cancer CenterLos AngelesUnited States11
Yale School of MedicineNorth HavenUnited States1